Skip to content

Eurofins successfully certifies kits and software with French Association of Standards (AFNOR)

Thomas Beuls | Press Release | 5/02/2020

Freiburg, Germany | Boston, MA | Today, Eurofins GeneScan Technologies GmbH and UgenTec, Inc. announce the successful NF VALIDATION certification of five real-time PCR kits with the French Association of Standards (AFNOR). The submission and approval are part of an ongoing strategic partnership between Eurofins Genescan Technologies, a provider of RNA / DNA detection kits and UgenTec, a software company focused on standardizing and automation PCR workflow and analysis.

Within this collaboration, Eurofins Genescan Technologies successfully validated and registered an automated analysis pipeline implemented on UgenTec’s FastFinder software platform for the BACGene E. coli O157:H7, BACGene Salmonella spp., BACGene Listeria Multiplex, BACGene Listeria monocytogenes, and BACGene Listeria spp. assays. With FastFinder, all assays can be analyzed and reported with minimum hands-on-time, while standardizing interpretation of results.

“Delivering products that are certified, validated and rigidly tested is key to Eurofins’ strategy” said Dr. Nicholas Krohn, Managing Director at Eurofins Genescan Technologies, “Supplying the customer with a complete solution not only simplifies the work our customers have to do to analyze our tests, it also helps standardizing the evaluation.”

“Enabling our partners to simplify their regulatory strategy is one of the key drivers in all of our partnerships. Whether it happens in context of the new IVDR, the FDA, AFNOR or other regulatory approval, UgenTec builds its platform to enable compliance excellence.” said Steven Verhoeven, CEO at UgenTec.

About Eurofins Genescan Technologies

Building on the experience and scientific excellence of the Eurofins Group, Eurofins GeneScan Technologies is a provider of diagnostic technologies in the field of Food, Feed and Seed Safety. Eurofins GeneScan Technologies offers a broad range of product kits for food pathogens, GMOs, animal and plant species detection and DNA/RNA extraction.

The in-house R&D teams have expertise in developing a wide range of assays. Uncompromising quality and fast results are key to our service.

Boston, San Francisco, Stockholm – January 12, 2023